Mankind Pharma Ltd
Tue 4/08/2026,10:23:0 BSE: MANKIND
Mankind Pharma Ltd
Tue 4/08/2026,10:9:59 NSE: MANKIND
Tue 4/08/2026,10:23:0
Mankind Pharma Ltd
Tue 4/08/2026,10:23:0 | BSE : MANKIND
Mankind Pharma Ltd
Tue 4/08/2026,10:9:59 | NSE : MANKIND
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 2496.55
Previous Close
₹ 2474.45
Volume
8821
Mkt Cap ( ₹ Cr)
₹ 101737.43
High
₹ 2496.55
Low
₹ 2459.35
52 Week High
₹ 2670.00
52 Week Low
₹ 1909.90
Book Value Per Share
₹ 394.69
Dividend Yield
₹ 0.04
Face Value
₹₹1.00
TTM EPS
49.46
TTM PE
50.03
P/B
6.27
Open
₹ 2483.00
Previous Close
₹ 2483.00
Volume
187005
Mkt Cap ( ₹ Cr)
₹ 101737.43
High
₹ 2487.00
Low
₹ 2459.90
52 Week High
₹ 2674.00
52 Week Low
₹ 1909.70
Book Value Per Share
₹ 394.69
Dividend Yield
0.04
Face Value
₹ 1.00
TTM EPS
49.46
TTM PE
50.03
P/B
6.27
What's Your Call?
Collective community sentiment on Mankind Pharma Ltd
Your Vote -
Buy
44.29%
Hold
24.29%
Sell
31.43%
44.29%
140 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
1030%
Sell Order Quantity
-930%
Bid Price
Qty
2458.20
750
2458.00
121
2458.00
451
2458.00
12
2458.00
5
Bid Total
36291
Bid Price
Qty
2459.50
14
2460.00
278
2460.00
11
2460.00
19
0.00
11
Bid Total
-32768
Option Chain
Analyzes market sentiment, predicts Mankind Pharma Ltd' movement.
| Call Price | Open interest | Strike Price | Put Price | Open interest |
|---|
News
Media spotlight triggers stock stock attention, sentiment.
-
Mankind Pharma - Copy of Newspaper Publication
31 Jul 2026, 3:02PM Mankind Pharma Limited has informed the Exchange about Copy of Newspaper Publication -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
30 Jul 2026, 8:31PM Investor Conference call for Q1FY27 - Audio Recording -
Mankind Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
30 Jul 2026, 8:28PM Mankind Pharma Limited has informed the Exchange about Link of Recording -
Mankind Pharma - General Updates
30 Jul 2026, 4:01PM Please find attached certificate under Regulation 54 of the SEBI (LODR) Regulations, 2015 -
Mankind Pharma - Compliances-Reg. 54 - Asset Cover details
30 Jul 2026, 3:59PM Please find attached certificate under Regulation 54 of the SEBI (LODR) Regulations, 2015 -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
30 Jul 2026, 3:55PM Please find attached press release on financial results of the Company for Q1FY27 -
Mankind Pharma - Press Release
30 Jul 2026, 3:53PM Mankind Pharma Limited has informed the Exchange regarding a press release dated July 30, 2026, titled ""Press Release on Financial Results for Q1FY27 -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation
30 Jul 2026, 3:48PM Please find attached investor presentation for Q1FY27 -
Mankind Pharma - Investor Presentation
30 Jul 2026, 3:46PM Mankind Pharma Limited has informed the Exchange about Investor Presentation -
Mankind Pharma - Approval For Issuance Of Corporate Guarantee
30 Jul 2026, 3:41PM Board of Directors of the Company in its meeting held today has inter-alia considered and approved the issuance of corproate guarantee in favour of Bh -
Mankind Pharma - Giving guarantees/indemnity/ becoming a surety for third party
30 Jul 2026, 3:31PM Mankind Pharma Limited has informed the Exchange about Giving guarantees/indemnity/ becoming a surety for third party -
Mankind Pharma - Un-Audited Financial Results Of The Company For The Quarter Ended On June 30, 2026
30 Jul 2026, 3:29PM Please find attached un-audited financial results of the Company for the quarter ended on June 30, 2026 -
Mankind Pharma - Board Meeting Outcome for Outcome Of Board Meeting
30 Jul 2026, 3:23PM Outcome of Board Meeting -
Mankind Pharma - Outcome of Board Meeting
30 Jul 2026, 3:22PM Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. -
Mankind Pharma - General Updates
27 Jul 2026, 6:30PM Final update on Stake Sale of Broadway Hospitality Services Private Limited -
Mankind Pharma - Final Update On Stake Sale Of Broadway Hospitality Services Private Limited
27 Jul 2026, 6:14PM Intimation under Regulation 30 of the SEBI LODR -
Mankind Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
20 Jul 2026, 8:20PM As of June 2026, 72.63% is owned by Indian Promoters and 27.37% by Public. <p align=justify> Institutional holds 24.84% (Insurance Companies 1.54%) an -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17 Jul 2026, 3:40PM Please find attached intimation regarding investor conference call for Q1FY27. -
Mankind Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
17 Jul 2026, 3:36PM Mankind Pharma Limited has informed the Exchange about Schedule of meet -
Mankind Pharma - Board Meeting Intimation for Approval Of Financial Results
16 Jul 2026, 4:32PM Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and a -
Mankind Pharma - Acquisition
11 Jul 2026, 1:29PM Mankind Pharma Limited has informed the Exchange about Acquisition -
Mankind Pharma - Diversification/Disinvestment
11 Jul 2026, 1:27PM Mankind Pharma Limited has informed the Exchange about Diversification/Disinvestment -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Acquisition
11 Jul 2026, 1:27PM Board of Directors of the Company in its meeting held today i.e., July 11, 2026 has approved the incorporation of a wholly owned subsidiary in Netherl -
Mankind Pharma - Outcome of Board Meeting
11 Jul 2026, 1:24PM Mankind Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 11, 2026. -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
11 Jul 2026, 1:31PM Board of Directors of the Company has approved the divestment of 100 % stake held in Broadway Hospitality Services Private Limited, a wholly owned sub -
Mankind Pharma - Board Meeting Outcome for Outcome Of Board Meeting
11 Jul 2026, 1:23PM Please find attached Outcome of Board Meeting held on July 11, 2026 -
Mankind Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Jul 2026, 11:12AM Please find attached certificate under Regulation 74(5) of the SEBI DP Regulations, 2018 for the quarted ended on June 30, 2026 -
Mankind Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 Jul 2026, 11:09AM Mankind Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 -
Mankind Pharma - Copy of Newspaper Publication
10 Jul 2026, 9:41AM Mankind Pharma Limited has informed the Exchange about Copy of Newspaper Publication -
Mankind Pharma - Shareholders meeting
9 Jul 2026, 4:37PM Mankind Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 04, 2026 -
Mankind Pharma - Business Responsibility and Sustainability Reporting (BRSR)
9 Jul 2026, 5:04PM Please find attached BRSR Report for the financial year 2025-26 -
Mankind Pharma - Regulation 53 (1) Annual Report.
9 Jul 2026, 4:56PM Please find attached Annual Report of the Company for financial year 2025-26 -
Mankind Pharma - Reg. 34 (1) Annual Report.
9 Jul 2026, 4:47PM Please find attached Annual Report of the Company for the financial year 2025-26 -
Mankind Pharma - Notice Of 35Th AGM
9 Jul 2026, 4:35PM Please find attached notice of 35th Annual General Meeting of the Company -
Mankind Pharma - Copy of Newspaper Publication
1 Jul 2026, 11:20AM Mankind Pharma Limited has informed the Exchange about Copy of Newspaper Publication -
Mankind Pharma - General Updates
30 Jun 2026, 11:55AM Mankind Pharma Limited has informed the Exchange about General Updates -
Mankind Pharma - Intimation Of Date Of AGM
30 Jun 2026, 11:59AM Please find attached Intimation of the date of Thirty Fifth (35th) Annual General Meeting of the Company. -
Mankind Pharma - Trading Window
25 Jun 2026, 12:29PM Mankind Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2 -
Mankind Pharma - Disclosure under SEBI Takeover Regulations
10 Jun 2026, 3:57PM ÿRamesh Junejaÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Ac -
Mankind Pharma - Cessation
8 Jun 2026, 10:34PM Mankind Pharma Limited has informed the Exchange regarding Cessation of Mr Prateek Dubey as SMP of the company w.e.f. Jun 08, 2026. -
Mankind Pharma - Appointment
8 Jun 2026, 10:32PM Mankind Pharma Limited has informed the Exchange regarding Appointment of Mr Nilesh Kulkarni as SMP of the company w.e.f. Jun 08, 2026. -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Change in Management
8 Jun 2026, 10:22PM Please find attached Intimation regarding Change in Management. -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
8 Jun 2026, 6:16PM Allotment of 86,778 Equity Shares under Mankind Employee Stock Option Plan 2022 (\ESOP PLAN\) -
Mankind Pharma - Allotment of Securities
8 Jun 2026, 6:14PM Mankind Pharma Limited has informed the Exchange regarding allotment of 86778 securities pursuant to ESOP/ESPS at its meeting held on Jun 08, 2026 -
Mankind Pharma - Acquisition
2 Jun 2026, 5:45PM Mankind Pharma Limited has informed the Exchange about Acquisition -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Acquisition
2 Jun 2026, 5:38PM Please find attached Intimation regarding acquisition of stake by a wholly owned subsidiary company. -
Mankind Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
27 May 2026, 4:11PM Mankind Pharma Limited has informed the Exchange about Schedule of meet -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
27 May 2026, 4:15PM Please find attached intimation regarding participation in investor conference -
Mankind Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
26 May 2026, 5:02PM Mankind Pharma Limited has informed the Exchange about Transcript -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
26 May 2026, 5:01PM Please find attached transcript of the Investor Conference Call held on May 20, 2026 -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
20 May 2026, 9:16PM Intimation of participation in the Investors Meeting -
Mankind Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
20 May 2026, 9:12PM Mankind Pharma Limited has informed the Exchange about Schedule of meet -
Mankind Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
20 May 2026, 4:03PM Mankind Pharma Limited has informed the Exchange about Link of Recording -
Mankind Pharma - Copy of Newspaper Publication
20 May 2026, 11:19AM Mankind Pharma Limited has informed the Exchange about Copy of Newspaper Publication -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
20 May 2026, 4:07PM Investor Conference Call for Q4 & FY26 - Audio Recording -
Mankind Pharma - Press Release
19 May 2026, 8:08PM Mankind Pharma Limited has informed the Exchange regarding a press release dated May 19, 2026, titled ""Press Release Q4FY26 & FY26"". -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
19 May 2026, 8:06PM Press Release for Q4FY26 & FY26 -
Mankind Pharma - Investor Presentation
19 May 2026, 8:00PM Mankind Pharma Limited has informed the Exchange about Investor Presentation -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation
19 May 2026, 8:00PM Investor Presentation for Q4&FY26 -
Mankind Pharma Q4 net profit jumps 86.58% at Rs 713.61 cr
19 May 2026, 7:50PM The company reported standalone net profit of Rs 713.61 crore for the quarter ended March 31, 2026 as compared to Rs 382.46 crore in the same period l -
Mankind Pharma - Resignation of Director/KMP/SMP
19 May 2026, 7:48PM Mankind Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
19 May 2026, 7:36PM Intimation regarding allotment of 80,872 Equity Shares under Mankind Employee Stock Option Plan 2022 -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Change in Management
19 May 2026, 7:31PM Cessation of Mr. Pramod Gokhale as SMP and Re-appointment of Mr. Satish Kumar Sharma as Whole Time Director and Re-appointment of Cost Auditor of the -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Acquisition
19 May 2026, 7:27PM Please find attached intimation under Regulation 30 of SEBI (LODR) Regualtions, 2015 -
Mankind Pharma - ESOP/ESOS/ESPS
19 May 2026, 7:26PM Mankind Pharma Limited has informed the Exchange regarding Allotment of 80872 Shares. -
Mankind Pharma - Board Meeting Outcome for Please Find Attached The Audited Financial Results For The Quarter And Financial Y
19 May 2026, 7:24PM Please find attached Audited Financail Results for the quarter and year ended March 31, 2026 -
Mankind Pharma - Cessation
19 May 2026, 7:22PM Mankind Pharma Limited has informed the Exchange regarding Cessation of Mr Pramod Gokhale as Other of the company w.e.f. May 31, 2026. -
Mankind Pharma - Financial Results For The Quarter And Financial Year Ended March 31, 2026
19 May 2026, 7:21PM Please find attached the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026 -
Mankind Pharma - Appointment
19 May 2026, 7:19PM Mankind Pharma Limited has informed the Exchange regarding Appointment of Ms M. K. Kulshrestha & Associates, Cost Accountants as Other of the company -
Mankind Pharma - Appointment
19 May 2026, 7:17PM Mankind Pharma Limited has informed the Exchange regarding Appointment of Mr Satish Kumar Sharma as Executive Director of the company w.e.f. September -
Mankind Pharma - Acquisition
19 May 2026, 7:15PM Mankind Pharma Limited has informed the Exchange about Acquisition -
Mankind Pharma - Outcome of Board Meeting
19 May 2026, 7:13PM Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. -
Mankind Pharma - Credit Rating
12 May 2026, 6:25PM Mankind Pharma Limited has informed the Exchange about Credit Rating -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Credit Rating
12 May 2026, 6:18PM Please find attached Intimation of Credit Rating reaffirmed and assigned by ICRA Limited -
Mankind Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
8 May 2026, 7:28PM Mankind Pharma Limited has informed the Exchange about Schedule of meet -
Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
8 May 2026, 7:22PM Please find attached Intimation of Investor Conference Call for Q4FY26 & FY26 -
Mankind Pharma - Board Meeting Intimation for Inter Alia, Consider And Approve The Standalone And Consolidated Audited Financ
7 May 2026, 6:49PM Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and a -
Mankind Pharma acquires Rivotril brand for India
18 Mar 2026 , 10:35AM Rivotril widely prescribed for mgmt of neurological & psychiatric conditions -
Mankind Pharma
18 Sep 2024 , 10:52AM Mankind Pharma : Company's board to consider raising funds via NCDs, commercial papers, other debt securities among others on September 20. (Stock not under coverage) -
Mankind Pharma
10 Jul 2024 , 10:34AM Hema CIPEF to sell 0.9% stake worth Rs 763crore. Deal is expected at Rs 2061/share which is at 2% discount to previous closing price. Hema CIPEF currently owns 2.22% stake. -
Mankind Pharma
14 May 2024 , 12:15PM The Company is looking to acquire Bharat Serum and vaccines from PE Company Advent which has 100% ownership of Bharat Serum & vaccines & now is looking to exit. Positive read through.
Key fundamentals
Evaluate the intrinsic value of Mankind Pharma Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 21885.2 | 21888.52 | 9623.8091 | 7783.911 | 6756.6684 |
| Liabilities | 21885.2 | 21888.52 | 9623.8091 | 7783.911 | 6756.6684 |
| Equity | 41.28 | 41.26 | 40.0588 | 40.0588 | 40.0588 |
| Gross Profit | 3085.92 | 2562.55 | 2325.1047 | 1697.3814 | 1799.6143 |
| Net Profit | 2037.56 | 1945.48 | 1823.4096 | 1248.258 | 1335.1306 |
| Cash From Operating Activities | 2751.99 | 2322.16 | 1982.9732 | 1798.9871 | 812.2873 |
| NPM(%) | 19.55 | 20.48 | 19.68 | 15.35 | 18.39 |
| Revenue | 10421.18 | 9497.8 | 9264.8093 | 8127.1532 | 7257.0359 |
| Expenses | 7335.26 | 6935.25 | 6939.7046 | 6429.7718 | 5457.4216 |
| ROE(%) | 12.5 | 11.93 | 11.18 | 7.65 | 8.19 |
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 22765.39 | 23051.21 | 9771.8239 | 7785.9293 | 7189.383 |
| Liabilities | 22765.39 | 23051.21 | 9771.8239 | 7785.9293 | 7189.383 |
| Equity | 41.28 | 41.26 | 40.0588 | 40.0588 | 40.059 |
| Gross Profit | 3617.41 | 3017.93 | 2535.0721 | 1900.6366 | 1989.352 |
| Net Profit | 1912.93 | 1990.96 | 1912.8967 | 1281.8591 | 1433.475 |
| Cash From Operating Activities | 3121.29 | 2413.38 | 2152.445 | 1813.3017 | 919.776 |
| NPM(%) | 13.39 | 16.3 | 18.5 | 14.65 | 18.42 |
| Revenue | 14277.64 | 12207.44 | 10334.7746 | 8749.433 | 7781.555 |
| Expenses | 10660.23 | 9189.51 | 7799.7025 | 6848.7964 | 5792.203 |
| ROE(%) | 11.73 | 12.21 | 11.73 | 7.86 | 8.79 |
Shareholding Pattern
Promotors
72.63%
Institutions
24.84%
Public
1.29%
Others
1.24%
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 08 Aug 2025 | 1 | 100 | 0.04 | 2567.2 |
| From Year | To Year | Class of Share | Authorized Capital(Crores) | Issued Capital(Crores) | Paid Up Shares(NOS) | Paid Up Face Value | Paid Up Capital(Crores) |
|---|---|---|---|---|---|---|---|
| 2025 | 2026 | Equity Share | 227.79 | 41.28 | 412828328.00 | 1 | 41.28 |
| 2024 | 2025 | Equity Share | 227.79 | 41.26 | 412578527.00 | 1 | 41.26 |
| 2023 | 2024 | Equity Share | 41.35 | 40.06 | 400588440.00 | 1 | 40.06 |
| 2022 | 2023 | Equity Share | 41.35 | 40.06 | 400588440.00 | 1 | 40.06 |
| 2021 | 2022 | Equity Share | 41.00 | 40.06 | 400588440.00 | 1 | 40.06 |
| 2020 | 2021 | Equity Share | 41.00 | 40.06 | 400588440.00 | 1 | 40.06 |
| Announcement Date | Price | Bonus Ratio | Record Date |
|---|
| Fund | Market Value(CR) | % Hold |
|---|---|---|
| ICICI Pru PHD (G) | 462.19 | 6.98 |
| ICICI Pru PHD (I) | 462.19 | 6.98 |
| ICICI Pru PHD DP (G) | 462.19 | 6.98 |
| ICICI Pru PHD DP (I) | 462.19 | 6.98 |
| PGIM Healthcare (G) | 5.36 | 5.19 |
| PGIM Healthcare (I) | 5.36 | 5.19 |
| PGIM Healthcare DP (G) | 5.36 | 5.19 |
| PGIM Healthcare DP (I) | 5.36 | 5.19 |
| Tata NifMidSmHealth (G) | 8.32 | 4.56 |
| Tata NifMidSmHealth (I) | 8.32 | 4.56 |
| Tata NifMidSmHealth (I-Rein) | 8.32 | 4.56 |
| Tata NifMidSmHealthD (G) | 8.32 | 4.56 |
| Tata NifMidSmHealthD (I) | 8.32 | 4.56 |
| Tata NifMidSmHealthD (I-Rein) | 8.32 | 4.56 |
| MotilalNifMidSmHea (G) | 1.82 | 4.54 |
| MotilalNifMidSmHeaDP (G) | 1.82 | 4.54 |
| Edelweiss Focused (G) | 42.72 | 4.15 |
| Edelweiss Focused (I) | 42.72 | 4.15 |
| Edelweiss Focused DP (G) | 42.72 | 4.15 |
| Edelweiss Focused DP (I) | 42.72 | 4.15 |
| Nippon Pharma (B) | 364.33 | 4.03 |
| Nippon Pharma (G) | 364.33 | 4.03 |
| Nippon Pharma (I) | 364.33 | 4.03 |
| Nippon Pharma DP (B) | 364.33 | 4.03 |
| Nippon Pharma DP (G) | 364.33 | 4.03 |
| Nippon Pharma DP (I) | 364.33 | 4.03 |
| AdityaBSL Phar&Hea (G) | 39.60 | 3.92 |
| AdityaBSL Phar&Hea (I) | 39.60 | 3.92 |
| AdityaBSL Phar&HeaDP (G) | 39.60 | 3.92 |
| AdityaBSL Phar&HeaDP (I) | 39.60 | 3.92 |
| Tata IndiaPharma (G) | 56.01 | 3.85 |
| Tata IndiaPharma (I) | 56.01 | 3.85 |
| Tata IndiaPharma (I-Rein) | 56.01 | 3.85 |
| Tata IndiaPharma DP (G) | 56.01 | 3.85 |
| Tata IndiaPharma DP (I-Payo) | 56.01 | 3.85 |
| Tata IndiaPharma DP (I-Rein) | 56.01 | 3.85 |
| Tata MidCap (G) | 203.65 | 3.47 |
| Tata MidCap (I) | 203.65 | 3.47 |
| Tata MidCap (IDCWR) | 203.65 | 3.47 |
| Tata MidCap DP (G) | 203.65 | 3.47 |
| Tata MidCap DP (I) | 203.65 | 3.47 |
| Tata MidCap DP (IDCWR) | 203.65 | 3.47 |
| Kotak Healthcare (G) | 22.91 | 3.38 |
| Kotak Healthcare (I) | 22.91 | 3.38 |
| Kotak Healthcare DP (G) | 22.91 | 3.38 |
| Kotak Healthcare DP (I) | 22.91 | 3.38 |
| MotilalNifMidSmCon (G) | 0.78 | 3.24 |
| MotilalNifMidSmConDP (G) | 0.78 | 3.24 |
| Franklin Opportun DP (G) | 289.80 | 3.15 |
| Franklin Opportun DP (I) | 289.80 | 3.15 |
| Franklin Opportuniti (G) | 289.80 | 3.15 |
| Franklin Opportuniti (I) | 289.80 | 3.15 |
| Franklin Opportuniti (I-Rein) | 289.80 | 3.15 |
| ICICI PruNifPharma (G) | 4.23 | 3.11 |
| ICICI PruNifPharma (I) | 4.23 | 3.11 |
| ICICI PruNifPharmaDP (G) | 4.23 | 3.11 |
| ICICI PruNifPharmaDP (I) | 4.23 | 3.11 |
| NipponInd NiftyPharm (G) | 50.51 | 3.11 |
| HSBC Focused (G) | 53.46 | 3.10 |
| HSBC Focused (I) | 53.46 | 3.10 |
| HSBC Focused DP (G) | 53.46 | 3.10 |
| HSBC Focused DP (I) | 53.46 | 3.10 |
| BaroBNPHealth&Well (G) | 16.55 | 2.99 |
| BaroBNPHealth&Well (I) | 16.55 | 2.99 |
| BaroBNPHealth&WellDP (G) | 16.55 | 2.99 |
| BaroBNPHealth&WellDP (I) | 16.55 | 2.99 |
| Quant Quantamental (G) | 49.23 | 2.98 |
| Quant Quantamental (I) | 49.23 | 2.98 |
| Quant QuantamentalDP (G) | 49.23 | 2.98 |
| Quant QuantamentalDP (I) | 49.23 | 2.98 |
| SBI HealthcareOpp (G) | 142.55 | 2.85 |
| SBI HealthcareOpp (I) | 142.55 | 2.85 |
| SBI HealthcareOpp (IDCWR) | 142.55 | 2.85 |
| SBI HealthcareOppDP (G) | 142.55 | 2.85 |
| SBI HealthcareOppDP (I) | 142.55 | 2.85 |
| SBI HealthcareOppDP (IDCWR) | 142.55 | 2.85 |
| ITI Pharma&HeaCare (G) | 7.16 | 2.84 |
| ITI Pharma&HeaCare (I) | 7.16 | 2.84 |
| ITI Pharma&HeaCareDP (G) | 7.16 | 2.84 |
| ITI Pharma&HeaCareDP (I) | 7.16 | 2.84 |
| AxisNifHealthcareETF (G) | 0.63 | 2.65 |
| DSP NifHealthcIndx (G) | 0.58 | 2.65 |
| DSP NifHealthcIndx (I) | 0.58 | 2.65 |
| DSP NifHealthcIndxDP (G) | 0.58 | 2.65 |
| DSP NifHealthcIndxDP (I) | 0.58 | 2.65 |
| DSP NiftyHealthcaETF (G) | 0.46 | 2.65 |
| AdityaBSL NifHealthC (G) | 2.17 | 2.65 |
| ICICI NiftyHealthETF (G) | 5.86 | 2.65 |
| HSBC Midcap (G) | 379.93 | 2.47 |
| HSBC Midcap (I) | 379.93 | 2.47 |
| HSBC Midcap (IDCWR) | 379.93 | 2.47 |
| HSBC Midcap DP (G) | 379.93 | 2.47 |
| HSBC Midcap DP (I) | 379.93 | 2.47 |
| BOI Flexi Cap (G) | 64.15 | 2.45 |
| BOI Flexi Cap (I) | 64.15 | 2.45 |
| BOI Flexi Cap DP (G) | 64.15 | 2.45 |
| BOI Flexi Cap DP (I) | 64.15 | 2.45 |
| PGIM Midcap (G) | 263.83 | 2.40 |
| PGIM Midcap (I) | 263.83 | 2.40 |
| PGIM Midcap DP (G) | 263.83 | 2.40 |
| PGIM Midcap DP (I) | 263.83 | 2.40 |
| MotilalBSESeIPOETF (G) | 0.13 | 2.40 |
| Mirae BSESeIPOETF (G) | 0.51 | 2.39 |
| LIC Healthcare (G) | 2.18 | 2.36 |
| LIC Healthcare (I) | 2.18 | 2.36 |
| LIC Healthcare DP (G) | 2.18 | 2.36 |
| LIC Healthcare DP (I) | 2.18 | 2.36 |
| MiraeNif500HelaETF (G) | 0.29 | 2.14 |
| MiraeAsset Health (G) | 68.59 | 2.11 |
| MiraeAsset Health (I) | 68.59 | 2.11 |
| MiraeAsset Health DP (G) | 68.59 | 2.11 |
| MiraeAsset Health DP (I) | 68.59 | 2.11 |
| HSBC Large Cap (G) | 38.18 | 2.10 |
| HSBC Large Cap (I) | 38.18 | 2.10 |
| HSBC Large Cap (IDCWR) | 38.18 | 2.10 |
| HSBC Large Cap DP (G) | 38.18 | 2.10 |
| HSBC Large Cap DP (I) | 38.18 | 2.10 |
| HSBC Large Cap DP (IDCWR) | 38.18 | 2.10 |
| Franklin Mid Cap (G) | 261.97 | 2.10 |
| Franklin Mid Cap (I) | 261.97 | 2.10 |
| Franklin Mid Cap (IDCWR) | 261.97 | 2.10 |
| Franklin Mid Cap DP (G) | 261.97 | 2.10 |
| Franklin Mid Cap DP (I) | 261.97 | 2.10 |
| ICICIPruInnovation (G) | 156.64 | 2.06 |
| ICICIPruInnovation (I) | 156.64 | 2.06 |
| ICICIPruInnovationDP (G) | 156.64 | 2.06 |
| ICICIPruInnovationDP (I) | 156.64 | 2.06 |
| Axis Flexi Cap (G) | 261.39 | 1.96 |
| Axis Flexi Cap (I) | 261.39 | 1.96 |
| Axis Flexi Cap DP (G) | 261.39 | 1.96 |
| Axis Flexi Cap DP (I) | 261.39 | 1.96 |
| BOI MidCap (G) | 14.00 | 1.93 |
| BOI MidCap (I) | 14.00 | 1.93 |
| BOI MidCap DP (G) | 14.00 | 1.93 |
| BOI MidCap DP (I) | 14.00 | 1.93 |
| Tata Large Cap DP (G) | 52.18 | 1.92 |
| Tata Large Cap DP (I) | 52.18 | 1.92 |
| Tata Large Cap DP (IDCWR) | 52.18 | 1.92 |
| Tata Large Cap RP (G) | 52.18 | 1.92 |
| Tata Large Cap RP (I) | 52.18 | 1.92 |
| Tata Large Cap RP (IDCWR) | 52.18 | 1.92 |
| SBI Large Cap (G) | 1036.81 | 1.88 |
| SBI Large Cap (I) | 1036.81 | 1.88 |
| SBI Large Cap (IDCWR) | 1036.81 | 1.88 |
| SBI Large Cap DP (G) | 1036.81 | 1.88 |
| SBI Large Cap DP (I) | 1036.81 | 1.88 |
| SBI Large Cap DP (IDCWR) | 1036.81 | 1.88 |
| Nippon Flexi Cap (G) | 175.24 | 1.83 |
| Nippon Flexi Cap (I) | 175.24 | 1.83 |
| Nippon Flexi Cap DP (G) | 175.24 | 1.83 |
| Nippon Flexi Cap DP (I) | 175.24 | 1.83 |
| Bandhan BSEHealthC (G) | 0.39 | 1.82 |
| Bandhan BSEHealthCDP (G) | 0.39 | 1.82 |
| Motilal BSEHealthETF (G) | 0.76 | 1.82 |
| HDFC LargeCap (G) | 697.37 | 1.79 |
| HDFC LargeCap (I) | 697.37 | 1.79 |
| HDFC LargeCap (IDCWR) | 697.37 | 1.79 |
| HDFC LargeCap DP (G) | 697.37 | 1.79 |
| HDFC LargeCap DP (I) | 697.37 | 1.79 |
| HDFC LargeCap DP (IDCWR) | 697.37 | 1.79 |
| Nippon GrowMidCap (B) | 865.50 | 1.76 |
| Nippon GrowMidCap (G) | 865.50 | 1.76 |
| Nippon GrowMidCap (I) | 865.50 | 1.76 |
| Nippon GrowMidCap (IDCWR) | 865.50 | 1.76 |
| Nippon GrowMidCap DP (B) | 865.50 | 1.76 |
| Nippon GrowMidCap DP (G) | 865.50 | 1.76 |
| Nippon GrowMidCap DP (I) | 865.50 | 1.76 |
| Nippon GrowMidCap IP (I) | 865.50 | 1.76 |
| Nippon GrowMidCap IP (I-Rein) | 865.50 | 1.76 |
| Edel MSCI DomWH45 (G) | 3.24 | 1.72 |
| Edel MSCI DomWH45 (I) | 3.24 | 1.72 |
| Edel MSCI DomWH45 DP (G) | 3.24 | 1.72 |
| Edel MSCI DomWH45 DP (I) | 3.24 | 1.72 |
| PGIM ELSSTaxSaver (G) | 12.02 | 1.69 |
| PGIM ELSSTaxSaver (I) | 12.02 | 1.69 |
| PGIM ELSSTaxSaver DP (G) | 12.02 | 1.69 |
| PGIM ELSSTaxSaver DP (I) | 12.02 | 1.69 |
| MahiMan ELSSTaxSav (G) | 14.47 | 1.64 |
| MahiMan ELSSTaxSav (I) | 14.47 | 1.64 |
| MahiManuELSSTaxSavDP (G) | 14.47 | 1.64 |
| MahiManuELSSTaxSavDP (I) | 14.47 | 1.64 |
| AdityaBSL FlexiCap (G) | 423.80 | 1.59 |
| AdityaBSL FlexiCap (I) | 423.80 | 1.59 |
| AdityaBSL FlexiCap (IDCWR) | 423.80 | 1.59 |
| AdityaBSL FlexiCapDP (G) | 423.80 | 1.59 |
| AdityaBSL FlexiCapDP (I) | 423.80 | 1.59 |
| AdityaBSL FlexiCapDP (IDCWR) | 423.80 | 1.59 |
| Franklin MultiCap (G) | 79.63 | 1.58 |
| Franklin MultiCap (I) | 79.63 | 1.58 |
| Franklin MultiCap DP (G) | 79.63 | 1.58 |
| Franklin MultiCap DP (I) | 79.63 | 1.58 |
| BaroBNP Childrens (G) | 1.91 | 1.57 |
| BaroBNP Childrens (I) | 1.91 | 1.57 |
| BaroBNP Childrens DP (G) | 1.91 | 1.57 |
| Kotak BusinesCycle (G) | 51.26 | 1.55 |
| Kotak BusinesCycle (I) | 51.26 | 1.55 |
| Kotak BusinesCycleDP (G) | 51.26 | 1.55 |
| Kotak BusinesCycleDP (I) | 51.26 | 1.55 |
| PGIM LargeMidcap (G) | 12.52 | 1.55 |
| PGIM LargeMidcap (I) | 12.52 | 1.55 |
| PGIM LargeMidcapDP (G) | 12.52 | 1.55 |
| PGIM LargeMidcapDP (I) | 12.52 | 1.55 |
| Union CorpBond (G) | 5.02 | 1.55 |
| Union CorpBond (I) | 5.02 | 1.55 |
| Union CorpBondDP (G) | 5.02 | 1.55 |
| Union CorpBondDP (I) | 5.02 | 1.55 |
| Axis Business Cycles (G) | 32.03 | 1.53 |
| Axis Business Cycles (I) | 32.03 | 1.53 |
| Axis BusinessCycleDP (G) | 32.03 | 1.53 |
| Axis BusinessCycleDP (I) | 32.03 | 1.53 |
| AdityaBSLLar&MidCaDP (G) | 87.52 | 1.51 |
| AdityaBSLLar&MidCaDP (I) | 87.52 | 1.51 |
| AdityaBSLLar&MidCaDP (IDCWR) | 87.52 | 1.51 |
| AdityaBSLLar&MidCap (G) | 87.52 | 1.51 |
| AdityaBSLLar&MidCap (I) | 87.52 | 1.51 |
| AdityaBSLLar&MidCap (IDCWR) | 87.52 | 1.51 |
| BOI Mid&SmlEqDeb (G) | 25.46 | 1.50 |
| BOI Mid&SmlEqDeb (I) | 25.46 | 1.50 |
| BOI Mid&SmlEqDeb (I-Rein) | 25.46 | 1.50 |
| BOI Mid&SmlEqDebDP (G) | 25.46 | 1.50 |
| BOI Mid&SmlEqDebDP (I) | 25.46 | 1.50 |
| MahiManu Flexi Cap (G) | 23.24 | 1.49 |
| MahiManu Flexi Cap (I) | 23.24 | 1.49 |
| MahiManu FlexiCapDP (G) | 23.24 | 1.49 |
| MahiManu FlexiCapDP (I) | 23.24 | 1.49 |
| PGIM Retirement (G) | 1.51 | 1.46 |
| PGIM Retirement (I) | 1.51 | 1.46 |
| PGIM Retirement DP (G) | 1.51 | 1.46 |
| PGIM Retirement DP (I) | 1.51 | 1.46 |
| Kotak Pioneer (G) | 55.65 | 1.44 |
| Kotak Pioneer (I) | 55.65 | 1.44 |
| Kotak Pioneer (IDCWR) | 55.65 | 1.44 |
| Kotak Pioneer DP (G) | 55.65 | 1.44 |
| Kotak Pioneer DP (I) | 55.65 | 1.44 |
| Kotak Pioneer DP (IDCWR) | 55.65 | 1.44 |
| HDFC BusinessCycle (G) | 36.76 | 1.36 |
| HDFC BusinessCycle (I) | 36.76 | 1.36 |
| HDFC BusinessCycleDP (G) | 36.76 | 1.36 |
| HDFC BusinessCycleDP (I) | 36.76 | 1.36 |
| AdityaBSL ESGIntSt (G) | 7.64 | 1.35 |
| AdityaBSL ESGIntSt (I) | 7.64 | 1.35 |
| AdityaBSL ESGIntStDP (G) | 7.64 | 1.35 |
| AdityaBSL ESGIntStDP (I) | 7.64 | 1.35 |
| DSP DyAssetAllo (G) | 50.26 | 1.34 |
| DSP DyAssetAllo (I) | 50.26 | 1.34 |
| DSP DyAssetAllo (IDCWR) | 50.26 | 1.34 |
| DSP DyAssetAllo DP (G) | 50.26 | 1.34 |
| DSP DyAssetAllo DP (I) | 50.26 | 1.34 |
| DSP DyAssetAllo DP (IDCWR) | 50.26 | 1.34 |
| AdityaBSL MfgEquiDP (G) | 16.29 | 1.33 |
| AdityaBSL MfgEquiDP (I) | 16.29 | 1.33 |
| AdityaBSL MfgEquiDP (IDCWR) | 16.29 | 1.33 |
| AdityaBSL MfgEquit (G) | 16.29 | 1.33 |
| AdityaBSL MfgEquit (I) | 16.29 | 1.33 |
| AdityaBSL MfgEquit (IDCWR) | 16.29 | 1.33 |
| Axis NiftyMidcap50 (G) | 9.01 | 1.29 |
| Axis NiftyMidcap50 (I) | 9.01 | 1.29 |
| Axis NiftyMidcap50DP (G) | 9.01 | 1.29 |
| Axis NiftyMidcap50DP (I) | 9.01 | 1.29 |
| BaroBNP Retirement (G) | 5.09 | 1.29 |
| BaroBNP Retirement (I) | 5.09 | 1.29 |
| BaroBNP RetirementDP (G) | 5.09 | 1.29 |
| BaroBNP RetirementDP (I) | 5.09 | 1.29 |
| Kotak NifMidcap50 (G) | 1.00 | 1.29 |
| Kotak NifMidcap50 (I) | 1.00 | 1.29 |
| Kotak NifMidcap50DP (G) | 1.00 | 1.29 |
| Kotak NifMidcap50DP (I) | 1.00 | 1.29 |
| PGIM LargeCap (G) | 6.94 | 1.29 |
| PGIM LargeCap (I) | 6.94 | 1.29 |
| PGIM LargeCap DP (G) | 6.94 | 1.29 |
| PGIM LargeCap DP (I) | 6.94 | 1.29 |
| HSBC MulAssetAllco (G) | 39.06 | 1.28 |
| HSBC MulAssetAllco (I) | 39.06 | 1.28 |
| HSBC MulAssetAllcoDP (G) | 39.06 | 1.28 |
| HSBC MulAssetAllcoDP (I) | 39.06 | 1.28 |
| Kotak NiftyMidcap50 (G) | 2.58 | 1.28 |
| PGIM Flexi Cap (G) | 74.24 | 1.28 |
| PGIM Flexi Cap (I) | 74.24 | 1.28 |
| PGIM Flexi Cap DP (G) | 74.24 | 1.28 |
| PGIM Flexi Cap DP (I) | 74.24 | 1.28 |
| UTI MultiCap (G) | 25.46 | 1.25 |
| UTI MultiCap DP (G) | 25.46 | 1.25 |
| BarBNP Eq Savings (G) | 3.37 | 1.21 |
| BarBNP Eq Savings (I) | 3.37 | 1.21 |
| BarBNP Eq Savings DP (G) | 3.37 | 1.21 |
| BarBNP Eq Savings DP (I) | 3.37 | 1.21 |
| LIC MF ELSS TaxSav (G) | 12.27 | 1.21 |
| LIC MF ELSS TaxSav (I) | 12.27 | 1.21 |
| LIC MF ELSS TaxSav (I-Rein) | 12.27 | 1.21 |
| LIC MF ELSS TaxSavDP (G) | 12.27 | 1.21 |
| LIC MF ELSS TaxSavDP (I) | 12.27 | 1.21 |
| BarBNP Midcap (G) | 30.27 | 1.20 |
| BarBNP Midcap (I) | 30.27 | 1.20 |
| BarBNP Midcap DP (G) | 30.27 | 1.20 |
| BarBNP Midcap DP (I) | 30.27 | 1.20 |
| MiraeAssetFlexiCap (G) | 50.79 | 1.19 |
| MiraeAssetFlexiCap (I) | 50.79 | 1.19 |
| MiraeAssetFlexiCapDP (G) | 50.79 | 1.19 |
| MiraeAssetFlexiCapDP (I) | 50.79 | 1.19 |
| SBI ESG ExclStra (G) | 63.64 | 1.19 |
| SBI ESG ExclStra (I) | 63.64 | 1.19 |
| SBI ESG ExclStra (IDCWR) | 63.64 | 1.19 |
| SBI ESG ExclStra DP (G) | 63.64 | 1.19 |
| SBI ESG ExclStra DP (I) | 63.64 | 1.19 |
| SBI ESG ExclStra DP (IDCWR) | 63.64 | 1.19 |
| HSBC Large&Mid Cap (G) | 61.87 | 1.16 |
| HSBC Large&Mid Cap (I) | 61.87 | 1.16 |
| HSBC Large&MidCapDP (G) | 61.87 | 1.16 |
| HSBC Large&MidCapDP (I) | 61.87 | 1.16 |
| Axis ELSS TaxSaver (G) | 354.61 | 1.11 |
| Axis ELSS TaxSaver (I) | 354.61 | 1.11 |
| Axis ELSS TaxSaver (I-Rein) | 354.61 | 1.11 |
| Axis ELSS TaxSaverDP (G) | 354.61 | 1.11 |
| Axis ELSS TaxSaverDP (I) | 354.61 | 1.11 |
| AdityaBSL LargeCap (AIDCWR) | 321.37 | 1.11 |
| AdityaBSL LargeCap (G) | 321.37 | 1.11 |
| AdityaBSL LargeCap (I-Annu) | 321.37 | 1.11 |
| AdityaBSL LargeCapDP (G) | 321.37 | 1.11 |
| AdityaBSL LargeCapDP (I) | 321.37 | 1.11 |
| AdityaBSL LargeCapDP (IDCWR) | 321.37 | 1.11 |
| TheWeComMulAsseAll (G) | 2.05 | 1.09 |
| TheWeComMulAsseAll (I) | 2.05 | 1.09 |
| TheWeComMulAsseAllDP (G) | 2.05 | 1.09 |
| TheWeComMulAsseAllDP (I) | 2.05 | 1.09 |
| Nippon ELSSTaxSav (G) | 162.66 | 1.09 |
| Nippon ELSSTaxSav (I) | 162.66 | 1.09 |
| Nippon ELSSTaxSav (I-Annu) | 162.66 | 1.09 |
| Nippon ELSSTaxSavDP (G) | 162.66 | 1.09 |
| Nippon ELSSTaxSavDP (I) | 162.66 | 1.09 |
| Nippon ELSSTaxSavDP (I-Annu) | 162.66 | 1.09 |
| Sundaram Mid Cap (G) | 152.74 | 1.09 |
| Sundaram Mid Cap (I) | 152.74 | 1.09 |
| Sundaram Mid Cap (I-Rein) | 152.74 | 1.09 |
| Sundaram Mid Cap-DP (G) | 152.74 | 1.09 |
| Sundaram Mid Cap-DP (I) | 152.74 | 1.09 |
| Sundaram Mid Cap-DP (IDCWR) | 152.74 | 1.09 |
| Kotak Small Cap - DP (G) | 202.56 | 1.08 |
| Kotak Small Cap - DP (I) | 202.56 | 1.08 |
| Kotak Small Cap - RP (G) | 202.56 | 1.08 |
| Kotak Small Cap - RP (I) | 202.56 | 1.08 |
| Kotak Small Cap - RP (IDCWR) | 202.56 | 1.08 |
| MiraeAsse SmallCap (G) | 50.80 | 1.05 |
| MiraeAsse SmallCap (I) | 50.80 | 1.05 |
| MiraeAsse SmallCapDP (G) | 50.80 | 1.05 |
| MiraeAsse SmallCapDP (I) | 50.80 | 1.05 |
| Union BusinesCycle (G) | 5.34 | 1.03 |
| Union BusinesCycle (I) | 5.34 | 1.03 |
| Union BusinesCycleDP (G) | 5.34 | 1.03 |
| Union BusinesCycleDP (I) | 5.34 | 1.03 |
| Mirae Asset Midcap (G) | 198.56 | 1.02 |
| Mirae Asset Midcap (I) | 198.56 | 1.02 |
| Mirae Asset MidcapDP (G) | 198.56 | 1.02 |
| Mirae Asset MidcapDP (I) | 198.56 | 1.02 |
| UTI LargeCap (G) | 121.52 | 1.01 |
| UTI LargeCap (I) | 121.52 | 1.01 |
| UTI LargeCap (I-Rein) | 121.52 | 1.01 |
| UTI LargeCap DP (G) | 121.52 | 1.01 |
| UTI LargeCap DP (I) | 121.52 | 1.01 |
| Edelweiss Mid Cap (G) | 175.03 | 0.99 |
| Edelweiss Mid Cap (I) | 175.03 | 0.99 |
| Edelweiss Mid Cap (I-Rein) | 175.03 | 0.99 |
| Edelweiss Mid Cap DP (G) | 175.03 | 0.99 |
| Edelweiss Mid Cap DP (I) | 175.03 | 0.99 |
| Axis RetirementDyn (G) | 2.77 | 0.98 |
| Axis RetirementDyn (I) | 2.77 | 0.98 |
| Axis RetirementDynDP (G) | 2.77 | 0.98 |
| Axis RetirementDynDP (I) | 2.77 | 0.98 |
| BOI LargeCap (G) | 2.14 | 0.97 |
| BOI LargeCap (I) | 2.14 | 0.97 |
| BOI LargeCap DP (G) | 2.14 | 0.97 |
| BOI LargeCap DP (I) | 2.14 | 0.97 |
| PGIM Multi Cap (G) | 4.06 | 0.94 |
| PGIM Multi Cap (I) | 4.06 | 0.94 |
| PGIM Multi Cap DP (G) | 4.06 | 0.94 |
| PGIM Multi Cap DP (I) | 4.06 | 0.94 |
| PGIM Multi Cap DP (I-Rein) | 4.06 | 0.94 |
| Axis RetirementAgg (G) | 6.36 | 0.90 |
| Axis RetirementAgg (I) | 6.36 | 0.90 |
| Axis RetirementAggDP (G) | 6.36 | 0.90 |
| Axis RetirementAggDP (I) | 6.36 | 0.90 |
| MahiManu AggHybrid (G) | 22.15 | 0.90 |
| MahiManu AggHybrid (I) | 22.15 | 0.90 |
| MahiManu AggHybrid (I-Mont) | 22.15 | 0.90 |
| MahiManu AggHybridDP (G) | 22.15 | 0.90 |
| MahiManu AggHybridDP (I) | 22.15 | 0.90 |
| MahiManu AggHybridDP (I-Mont) | 22.15 | 0.90 |
| Axis AggressiveHyb (G) | 12.90 | 0.89 |
| Axis AggressiveHyb (I) | 12.90 | 0.89 |
| Axis AggressiveHyb (I-Mont) | 12.90 | 0.89 |
| Axis AggressiveHyb (I-Quar) | 12.90 | 0.89 |
| Axis AggressiveHybDP (G) | 12.90 | 0.89 |
| Axis AggressiveHybDP (I) | 12.90 | 0.89 |
| Axis AggressiveHybDP (I-Mont) | 12.90 | 0.89 |
| Axis AggressiveHybDP (I-Quar) | 12.90 | 0.89 |
| Sundaram Agg Hyb (I-Mont) | 79.68 | 0.89 |
| Sundaram Agg Hyb (MIDCWR) | 79.68 | 0.89 |
| Sundaram Agg HybDP (G) | 79.68 | 0.89 |
| Sundaram Agg HybDP (I-Mont) | 79.68 | 0.89 |
| Sundaram Agg HybDP (MIDCWR) | 79.68 | 0.89 |
| Sundaram Agg HyEq (G) | 79.68 | 0.89 |
| TataNif500MulManuf (G) | 1.13 | 0.89 |
| TataNif500MulManuf (I) | 1.13 | 0.89 |
| TataNif500MulManuf (I-Rein) | 1.13 | 0.89 |
| TataNif500MulManufDP (G) | 1.13 | 0.89 |
| TataNif500MulManufDP (I) | 1.13 | 0.89 |
| TataNif500MulManufDP (I-Rein) | 1.13 | 0.89 |
| Aditya MultiAssAll (G) | 61.80 | 0.88 |
| Aditya MultiAssAll (I) | 61.80 | 0.88 |
| Aditya MultiAssAllDP (G) | 61.80 | 0.88 |
| Aditya MultiAssAllDP (I) | 61.80 | 0.88 |
| BarBNP MultiCap (G) | 29.27 | 0.88 |
| BarBNP MultiCap (I) | 29.27 | 0.88 |
| BarBNP MultiCap (I-Rein) | 29.27 | 0.88 |
| BarBNP MultiCap DP (G) | 29.27 | 0.88 |
| BarBNP MultiCap DP (I) | 29.27 | 0.88 |
| PGIM MulAssetAlloc (G) | 2.48 | 0.88 |
| PGIM MulAssetAlloc (I) | 2.48 | 0.88 |
| PGIM MulAssetAllocDP (G) | 2.48 | 0.88 |
| PGIM MulAssetAllocDP (I) | 2.48 | 0.88 |
| UTI MastrEqPlUnSch (I) | 24.30 | 0.88 |
| EdelweissLar&MiCap (G) | 40.49 | 0.86 |
| EdelweissLar&MiCap (I) | 40.49 | 0.86 |
| EdelweissLar&MiCap (I-Rein) | 40.49 | 0.86 |
| EdelweissLar&MiCapDP (G) | 40.49 | 0.86 |
| EdelweissLar&MiCapDP (I) | 40.49 | 0.86 |
| Motilal NifMid100ETF (G) | 7.60 | 0.86 |
| LICNifMidcap100ETF (G) | 5.61 | 0.85 |
| SBI UltraShDura DP (I-Dail) | 100.10 | 0.85 |
| SBI UltraShDura DP (I-Week) | 100.10 | 0.85 |
| SBI UltraShDura DP (WIDCWR) | 100.10 | 0.85 |
| SBI UltraShDura Gr (G) | 100.10 | 0.85 |
| SBI UltraShDuraDaily (I-Dail) | 100.10 | 0.85 |
| SBI UltraShDuraDP Gr (G) | 100.10 | 0.85 |
| SBI UltraShDuraWDiv (I) | 100.10 | 0.85 |
| Sundaram MulAstAll (G) | 27.83 | 0.85 |
| Sundaram MulAstAll (I) | 27.83 | 0.85 |
| Sundaram MulAstAll (I-Rein) | 27.83 | 0.85 |
| Sundaram MulAstAllDP (G) | 27.83 | 0.85 |
| Sundaram MulAstAllDP (I) | 27.83 | 0.85 |
| Sundaram MulAstAllDP (I-Rein) | 27.83 | 0.85 |
| Nippon Large Cap (B) | 448.29 | 0.84 |
| Nippon Large Cap (G) | 448.29 | 0.84 |
| Nippon Large Cap (I) | 448.29 | 0.84 |
| Nippon Large CapDP (B) | 448.29 | 0.84 |
| Nippon Large CapDP (G) | 448.29 | 0.84 |
| Nippon Large CapDP (I) | 448.29 | 0.84 |
| Tata Large & MidCap (G) | 66.19 | 0.84 |
| Tata Large&MidCap (I) | 66.19 | 0.84 |
| Tata Large&MidCap (IDCWR) | 66.19 | 0.84 |
| Tata Large&MidCap DP (G) | 66.19 | 0.84 |
| Tata Large&MidCap DP (I) | 66.19 | 0.84 |
| Tata Large&MidCap DP (IDCWR) | 66.19 | 0.84 |
| CanaraRob FlexiCap (G) | 110.98 | 0.83 |
| CanaraRob FlexiCap (I) | 110.98 | 0.83 |
| CanaraRob FlexiCapDP (G) | 110.98 | 0.83 |
| CanaraRob FlexiCapDP (I) | 110.98 | 0.83 |
| PGIM Balanced Adv (G) | 6.38 | 0.83 |
| PGIM Balanced Adv (I) | 6.38 | 0.83 |
| PGIM Balanced Adv DP (G) | 6.38 | 0.83 |
| PGIM Balanced Adv DP (I) | 6.38 | 0.83 |
| Sundaram Bal Adv DP (G) | 13.11 | 0.79 |
| Sundaram Bal Adv DP (I-Mont) | 13.11 | 0.79 |
| Sundaram Bal Adv DP (I-Mont) | 13.11 | 0.79 |
| Sundaram Bal Adv DP (MIDCWR) | 13.11 | 0.79 |
| Sundaram Balanced Ad (G) | 13.11 | 0.79 |
| Sundaram Balanced Ad (I-Mont) | 13.11 | 0.79 |
| Sundaram Balanced Ad (I-Mont) | 13.11 | 0.79 |
| Sundaram Balanced Ad (MIDCWR) | 13.11 | 0.79 |
| iSIF EqExT100LngSh (G) | 14.43 | 0.75 |
| iSIF EqExT100LngShDP (G) | 14.43 | 0.75 |
| HSBC ELSSTaxsaver (G) | 29.33 | 0.72 |
| HSBC ELSSTaxsaver (I) | 29.33 | 0.72 |
| HSBC ELSSTaxsaver (IDCWR) | 29.33 | 0.72 |
| HSBC ELSSTaxSaverDP (G) | 29.33 | 0.72 |
| HSBC ELSSTaxSaverDP (I) | 29.33 | 0.72 |
| HSBC ELSSTaxSaverDP (IDCWR) | 29.33 | 0.72 |
| Axis RetirementCon (G) | 0.34 | 0.71 |
| Axis RetirementCon (I) | 0.34 | 0.71 |
| Axis RetirementConDP (G) | 0.34 | 0.71 |
| Axis RetirementConDP (I) | 0.34 | 0.71 |
| Bandhan NifMidC150 (G) | 0.73 | 0.71 |
| Bandhan NifMidC150DP (G) | 0.73 | 0.71 |
| BarodaNifMidcap150 (G) | 0.07 | 0.71 |
| BarodaNifMidcap150DP (G) | 0.07 | 0.71 |
| HDFC NiftyMid150 (G) | 4.59 | 0.71 |
| HDFC NiftyMid150DP (G) | 4.59 | 0.71 |
| KotakNifMid150Indx (G) | 0.28 | 0.71 |
| KotakNifMid150Indx (I) | 0.28 | 0.71 |
| KotakNifMid150IndxDP (G) | 0.28 | 0.71 |
| KotakNifMid150IndxDP (I) | 0.28 | 0.71 |
| Nippon NifMidca150 (G) | 18.48 | 0.71 |
| Nippon NifMidca150 (I) | 18.48 | 0.71 |
| Nippon NifMidca150DP (G) | 18.48 | 0.71 |
| Nippon NifMidca150DP (I) | 18.48 | 0.71 |
| Nippon NiftyMid150 (G) | 25.48 | 0.71 |
| SBI Contra (G) | 338.07 | 0.71 |
| SBI Contra (I) | 338.07 | 0.71 |
| SBI Contra (IDCWR) | 338.07 | 0.71 |
| SBI Contra DP (G) | 338.07 | 0.71 |
| SBI Contra DP (I) | 338.07 | 0.71 |
| SBI Contra DP (IDCWR) | 338.07 | 0.71 |
| SBI NifMidcap150 (G) | 8.13 | 0.71 |
| SBI NifMidcap150 (I) | 8.13 | 0.71 |
| SBI NifMidcap150DP (G) | 8.13 | 0.71 |
| SBI NifMidcap150DP (I) | 8.13 | 0.71 |
| TataNifMidcap150 (G) | 2.09 | 0.71 |
| TataNifMidcap150 (I) | 2.09 | 0.71 |
| TataNifMidcap150 (I-Rein) | 2.09 | 0.71 |
| TataNifMidcap150DP (G) | 2.09 | 0.71 |
| TataNifMidcap150DP (I) | 2.09 | 0.71 |
| TataNifMidcap150DP (I-Rein) | 2.09 | 0.71 |
| UTI NifMidcap150 (G) | 0.51 | 0.71 |
| UTI NifMidcap150DP (G) | 0.51 | 0.71 |
| JioBR NifMidcap150DP (G) | 1.90 | 0.71 |
| Motilal Midcap 150 (G) | 26.31 | 0.71 |
| Motilal MidCap 150DP (G) | 26.31 | 0.71 |
| AdityaBSLNifMid150 (G) | 3.33 | 0.70 |
| AdityaBSLNifMid150 (I) | 3.33 | 0.70 |
| AdityaBSLNifMid150DP (G) | 3.33 | 0.70 |
| AdityaBSLNifMid150DP (I) | 3.33 | 0.70 |
| MiraeNifMidcap150ETF (G) | 12.78 | 0.70 |
| ICICI NifMidca150ETF (G) | 5.35 | 0.70 |
| ICICINifMid150IndeDP (G) | 8.44 | 0.70 |
| ICICINifMid150IndeDP (I) | 8.44 | 0.70 |
| ICICINifMid150Index (G) | 8.44 | 0.70 |
| ICICINifMid150Index (I) | 8.44 | 0.70 |
| Zerodha Nifty Mid150 (G) | 1.79 | 0.70 |
| GrowwNifMC150Index (G) | 0.11 | 0.70 |
| GrowwNifMC150Index (I) | 0.11 | 0.70 |
| GrowwNifMC150IndexDP (G) | 0.11 | 0.70 |
| GrowwNifMC150IndexDP (I) | 0.11 | 0.70 |
| GrowwNifMC150ETF (G) | 0.04 | 0.70 |
| DSP NifMC150ETF (G) | 0.04 | 0.70 |
| DSP NifMC150Index (G) | 0.11 | 0.70 |
| DSP NifMC150Index (I) | 0.11 | 0.70 |
| DSP NifMC150IndexDP (G) | 0.11 | 0.70 |
| DSP NifMC150IndexDP (I) | 0.11 | 0.70 |
| HDFC NifMidcap150ETF (G) | 1.11 | 0.70 |
| KotakNifMid150ETF (G) | 0.09 | 0.70 |
| Navi NifMidcap150 (G) | 2.74 | 0.70 |
| Navi NifMidcap150DP (G) | 2.74 | 0.70 |
| SBI NiMidcap150ETF (G) | 0.08 | 0.70 |
| UTI NifMidcap150ETF (G) | 0.10 | 0.70 |
| Bandhan Focused (G) | 13.50 | 0.65 |
| Bandhan Focused (I) | 13.50 | 0.65 |
| Bandhan Focused (IDCWR) | 13.50 | 0.65 |
| Bandhan Focused DP (G) | 13.50 | 0.65 |
| Bandhan Focused DP (I) | 13.50 | 0.65 |
| WhiteOak ESGBestIn (G) | 0.35 | 0.64 |
| WhiteOak ESGBestInDP (G) | 0.35 | 0.64 |
| WhiteOak Arbitrage (G) | 10.12 | 0.63 |
| WhiteOak ArbitrageDP (G) | 10.12 | 0.63 |
| CanaraRob LargeCap (G) | 100.69 | 0.60 |
| CanaraRob LargeCap (I) | 100.69 | 0.60 |
| CanaraRob LargeCap (I-Rein) | 100.69 | 0.60 |
| CanaraRob LargeCapDP (G) | 100.69 | 0.60 |
| CanaraRob LargeCapDP (I) | 100.69 | 0.60 |
| HSBC Aggre Hybrid (AIDCWR) | 30.95 | 0.55 |
| HSBC Aggre Hybrid (G) | 30.95 | 0.55 |
| HSBC Aggre Hybrid (I) | 30.95 | 0.55 |
| HSBC Aggre Hybrid (I-Annu) | 30.95 | 0.55 |
| HSBC Aggre Hybrid (IDCWR) | 30.95 | 0.55 |
| HSBC Aggre Hybrid DP (AIDCWR) | 30.95 | 0.55 |
| HSBC Aggre Hybrid DP (G) | 30.95 | 0.55 |
| HSBC Aggre Hybrid DP (I) | 30.95 | 0.55 |
| HSBC Aggre Hybrid DP (I-Annu) | 30.95 | 0.55 |
| AdityaBSL Consumpt (G) | 32.69 | 0.55 |
| AdityaBSL Consumpt (I) | 32.69 | 0.55 |
| AdityaBSL Consumpt (IDCWR) | 32.69 | 0.55 |
| AdityaBSL ConsumptDP (G) | 32.69 | 0.55 |
| AdityaBSL ConsumptDP (I) | 32.69 | 0.55 |
| AdityaBSL ConsumptDP (IDCWR) | 32.69 | 0.55 |
| BarBNP Con Hybrid (G) | 5.09 | 0.54 |
| BarBNP Con Hybrid (I-Mont) | 5.09 | 0.54 |
| BarBNP Con Hybrid (I-Quar) | 5.09 | 0.54 |
| BarBNP Con Hybrid DP (G) | 5.09 | 0.54 |
| BarBNP Con Hybrid DP (I-Mont) | 5.09 | 0.54 |
| BarBNP Con Hybrid DP (I-Quar) | 5.09 | 0.54 |
| Union Large&Mid (G) | 5.09 | 0.53 |
| Union Large&Mid (I) | 5.09 | 0.53 |
| Union Large&Mid DP (G) | 5.09 | 0.53 |
| Union Large&Mid DP (I) | 5.09 | 0.53 |
| WhiteOak MidCap (G) | 32.42 | 0.53 |
| WhiteOak MidCap (I) | 32.42 | 0.53 |
| WhiteOak MidCapDP (G) | 32.42 | 0.53 |
| WhiteOak MidCapDP (I) | 32.42 | 0.53 |
| Union ELSSTaxSaver (G) | 4.45 | 0.52 |
| Union ELSSTaxSaver (I) | 4.45 | 0.52 |
| Union ELSSTaxSaver (IDCWR) | 4.45 | 0.52 |
| Union ELSSTaxSaverDP (G) | 4.45 | 0.52 |
| Union ELSSTaxSaverDP (I) | 4.45 | 0.52 |
| Union ELSSTaxSaverDP (IDCWR) | 4.45 | 0.52 |
| Mirae BSE200EqlETF (G) | 0.10 | 0.52 |
| FranklinInd EqSav (G) | 3.18 | 0.51 |
| FranklinInd EqSav (I) | 3.18 | 0.51 |
| FranklinInd EqSav (I-Mont) | 3.18 | 0.51 |
| FranklinInd EqSav (I-Quar) | 3.18 | 0.51 |
| FranklinInd EqSav (IDCWR) | 3.18 | 0.51 |
| FranklinInd EqSavDP (G) | 3.18 | 0.51 |
| FranklinInd EqSavDP (I) | 3.18 | 0.51 |
| FranklinInd EqSavDP (I-Mont) | 3.18 | 0.51 |
| FranklinInd EqSavDP (I-Quar) | 3.18 | 0.51 |
| Bandhan Midcap (G) | 11.74 | 0.51 |
| Bandhan Midcap (I) | 11.74 | 0.51 |
| Bandhan Midcap DP (G) | 11.74 | 0.51 |
| Bandhan Midcap DP (I) | 11.74 | 0.51 |
| Bandhan Multi Cap (G) | 15.27 | 0.51 |
| Bandhan Multi Cap (I) | 15.27 | 0.51 |
| Bandhan Multi Cap DP (G) | 15.27 | 0.51 |
| Bandhan Multi Cap DP (I) | 15.27 | 0.51 |
| BOI Larg&MidCap (B) | 2.47 | 0.50 |
| BOI Larg&MidCap (G) | 2.47 | 0.50 |
| BOI Larg&MidCap (I) | 2.47 | 0.50 |
| BOI Larg&MidCap (I-Quar) | 2.47 | 0.50 |
| BOI Larg&MidCap (I-Rein) | 2.47 | 0.50 |
| BOI Larg&MidCap (Q) | 2.47 | 0.50 |
| BOI Larg&MidCap DP (B) | 2.47 | 0.50 |
| BOI Larg&MidCap DP (G) | 2.47 | 0.50 |
| BOI Larg&MidCap DP (I) | 2.47 | 0.50 |
| BOI Larg&MidCap DP (I-Quar) | 2.47 | 0.50 |
| BOI Larg&MidCap Eco (B) | 2.47 | 0.50 |
| BOI Larg&MidCap Eco (G) | 2.47 | 0.50 |
| BOI Larg&MidCap Eco (I) | 2.47 | 0.50 |
| BOI Larg&MidCap Eco (I-Quar) | 2.47 | 0.50 |
| BOI Larg&MidCap Eco (I-Rein) | 2.47 | 0.50 |
| BOI MfInfra (G) | 4.20 | 0.50 |
| BOI MfInfra (I) | 4.20 | 0.50 |
| BOI MfInfra (I-Quar) | 4.20 | 0.50 |
| BOI MfInfra (I-Rein) | 4.20 | 0.50 |
| BOI MfInfra (Q) | 4.20 | 0.50 |
| BOI MfInfraDP (G) | 4.20 | 0.50 |
| BOI MfInfraDP (I) | 4.20 | 0.50 |
| BOI MfInfraDP (I-Quar) | 4.20 | 0.50 |
| BOI Multi Cap (G) | 5.87 | 0.50 |
| BOI Multi Cap (I) | 5.87 | 0.50 |
| BOI Multi Cap DP (G) | 5.87 | 0.50 |
| BOI Multi Cap DP (I) | 5.87 | 0.50 |
| Union AggreHybrid (G) | 3.72 | 0.50 |
| Union AggreHybrid (I) | 3.72 | 0.50 |
| Union AggreHybrid DP (G) | 3.72 | 0.50 |
| Union AggreHybrid DP (I) | 3.72 | 0.50 |
| Navi NifMidSC400 (G) | 0.05 | 0.46 |
| Navi NifMidSC400DP (G) | 0.05 | 0.46 |
| Sundaram EqSav DP (G) | 4.81 | 0.46 |
| Sundaram EqSav DP (HIDCWR) | 4.81 | 0.46 |
| Sundaram EqSav DP (I-Half) | 4.81 | 0.46 |
| Sundaram EqSav DP (I-Half) | 4.81 | 0.46 |
| Sundaram EqSav DP (I-Quar) | 4.81 | 0.46 |
| Sundaram EqSav DP (IDCWQS) | 4.81 | 0.46 |
| Sundaram EqSav DP (QIDCWR) | 4.81 | 0.46 |
| Sundaram EqSav QD (I) | 4.81 | 0.46 |
| Sundaram EqSav QD (IDCWQS) | 4.81 | 0.46 |
| Sundaram EqSav QD (IDCWR) | 4.81 | 0.46 |
| Sundaram EqSavDiv (HIDCWR) | 4.81 | 0.46 |
| Sundaram EqSavDiv (I-Half) | 4.81 | 0.46 |
| Sundaram EqSavGr (G) | 4.81 | 0.46 |
| CanaraRob MultiCap (G) | 23.72 | 0.43 |
| CanaraRob MultiCap (I) | 23.72 | 0.43 |
| CanaraRob MultiCapDP (G) | 23.72 | 0.43 |
| CanaraRob MultiCapDP (I) | 23.72 | 0.43 |
| Union MulAssetAllo (G) | 4.07 | 0.42 |
| Union MulAssetAllo (I) | 4.07 | 0.42 |
| Union MulAssetAlloDP (G) | 4.07 | 0.42 |
| Union MulAssetAlloDP (I) | 4.07 | 0.42 |
| Nippon MulAssetAll (G) | 65.05 | 0.41 |
| Nippon MulAssetAll (I) | 65.05 | 0.41 |
| Nippon MulAssetAllDP (G) | 65.05 | 0.41 |
| Nippon MulAssetAllDP (I) | 65.05 | 0.41 |
| Union Balanced Advan (G) | 5.09 | 0.41 |
| Union Balanced Advan (I) | 5.09 | 0.41 |
| Union Balanced AdvDP (G) | 5.09 | 0.41 |
| Union Balanced AdvDP (I) | 5.09 | 0.41 |
| Axis Balanced Adv (G) | 15.45 | 0.40 |
| Axis Balanced Adv (I) | 15.45 | 0.40 |
| Axis Balanced Adv DP (G) | 15.45 | 0.40 |
| Axis Balanced Adv DP (I) | 15.45 | 0.40 |
| Axis Midcap (G) | 130.63 | 0.39 |
| Axis Midcap (I) | 130.63 | 0.39 |
| Axis Midcap (I-Rein) | 130.63 | 0.39 |
| Axis Midcap DP (G) | 130.63 | 0.39 |
| Axis Midcap DP (I) | 130.63 | 0.39 |
| WhiteOak BalAdv (G) | 8.54 | 0.39 |
| WhiteOak BalAdv DP (G) | 8.54 | 0.39 |
| WhiteOakAggrHybrid (G) | 1.20 | 0.39 |
| WhiteOakAggrHybridDP (G) | 1.20 | 0.39 |
| SBI LowDuration (FIDCWR) | 50.18 | 0.37 |
| SBI LowDuration (G) | 50.18 | 0.37 |
| SBI LowDuration (I-Dail) | 50.18 | 0.37 |
| SBI LowDuration (I-Fort) | 50.18 | 0.37 |
| SBI LowDuration (I-Mont) | 50.18 | 0.37 |
| SBI LowDuration (I-Week) | 50.18 | 0.37 |
| SBI LowDuration (MIDCWR) | 50.18 | 0.37 |
| SBI LowDuration (W) | 50.18 | 0.37 |
| SBI LowDuration DP (FIDCWR) | 50.18 | 0.37 |
| SBI LowDuration DP (G) | 50.18 | 0.37 |
| SBI LowDuration DP (I-Dail) | 50.18 | 0.37 |
| SBI LowDuration DP (I-Fort) | 50.18 | 0.37 |
| SBI LowDuration DP (I-Mont) | 50.18 | 0.37 |
| SBI LowDuration DP (I-Week) | 50.18 | 0.37 |
| SBI LowDuration DP (MIDCWR) | 50.18 | 0.37 |
| SBI LowDuration DP (WIDCWR) | 50.18 | 0.37 |
| SBI LowDuration IP (G) | 50.18 | 0.37 |
| SBI LowDuration IP (I-Dail) | 50.18 | 0.37 |
| SBI LowDuration IP (I-Week) | 50.18 | 0.37 |
| SBI LowDuration IP (W) | 50.18 | 0.37 |
| Edelweiss MultiCap (G) | 11.91 | 0.36 |
| Edelweiss MultiCap (I) | 11.91 | 0.36 |
| Edelweiss MultiCapDP (G) | 11.91 | 0.36 |
| Edelweiss MultiCapDP (I) | 11.91 | 0.36 |
| Zerodha NifLarMid DP (G) | 5.24 | 0.35 |
| ICICI NifLarMid250 (G) | 0.98 | 0.35 |
| ICICI NifLarMid250 (I) | 0.98 | 0.35 |
| ICICI NifLarMid250DP (G) | 0.98 | 0.35 |
| ICICI NifLarMid250DP (I) | 0.98 | 0.35 |
| Mirae NifLarMid250 (G) | 0.13 | 0.35 |
| Mirae NifLarMid250 (I) | 0.13 | 0.35 |
| Mirae NifLarMid250DP (G) | 0.13 | 0.35 |
| Mirae NifLarMid250DP (I) | 0.13 | 0.35 |
| Zerodha ELSSTaxSavDP (G) | 0.98 | 0.35 |
| ZerodNifMS40050:50DP (G) | 0.04 | 0.35 |
| EdelNifLar&Midcap (G) | 1.17 | 0.35 |
| EdelNifLar&Midcap (I) | 1.17 | 0.35 |
| EdelNifLar&MidcapDP (G) | 1.17 | 0.35 |
| EdelNifLar&MidcapDP (I) | 1.17 | 0.35 |
| EdelwNifLMid250ETF (G) | 0.54 | 0.35 |
| HDFC NifLarMC250 (G) | 1.58 | 0.35 |
| HDFC NifLarMC250DP (G) | 1.58 | 0.35 |
| Bandhan Retirement (G) | 0.61 | 0.34 |
| Bandhan Retirement (I) | 0.61 | 0.34 |
| Bandhan RetirementDP (G) | 0.61 | 0.34 |
| Bandhan RetirementDP (I) | 0.61 | 0.34 |
| WhiteOak BalHybrid (G) | 1.00 | 0.34 |
| WhiteOak BalHybridDP (G) | 1.00 | 0.34 |
| MiraeAsset ArbitraDP (G) | 11.90 | 0.32 |
| MiraeAsset ArbitraDP (I) | 11.90 | 0.32 |
| MiraeAsset Arbitrage (G) | 11.90 | 0.32 |
| MiraeAsset Arbitrage (I) | 11.90 | 0.32 |
| Bandhan BalanceAdv (G) | 6.82 | 0.31 |
| Bandhan BalanceAdv (I) | 6.82 | 0.31 |
| Bandhan BalanceAdv (IDCWR) | 6.82 | 0.31 |
| Bandhan BalanceAdvDP (G) | 6.82 | 0.31 |
| Bandhan BalanceAdvDP (I) | 6.82 | 0.31 |
| Bandhan BalanceAdvDP (IDCWR) | 6.82 | 0.31 |
| JM Arbitrage (A) | 1.08 | 0.28 |
| JM Arbitrage (B) | 1.08 | 0.28 |
| JM Arbitrage (B-Annu) | 1.08 | 0.28 |
| JM Arbitrage (B-Half) | 1.08 | 0.28 |
| JM Arbitrage (B-Quar) | 1.08 | 0.28 |
| JM Arbitrage (G) | 1.08 | 0.28 |
| JM Arbitrage (H) | 1.08 | 0.28 |
| JM Arbitrage (I) | 1.08 | 0.28 |
| JM Arbitrage (I-Annu) | 1.08 | 0.28 |
| JM Arbitrage (I-Half) | 1.08 | 0.28 |
| JM Arbitrage (I-Mont) | 1.08 | 0.28 |
| JM Arbitrage (I-Quar) | 1.08 | 0.28 |
| JM Arbitrage (I-Rein) | 1.08 | 0.28 |
| JM Arbitrage (Q) | 1.08 | 0.28 |
| JM Arbitrage DP (B) | 1.08 | 0.28 |
| JM Arbitrage DP (B-Annu) | 1.08 | 0.28 |
| JM Arbitrage DP (B-Half) | 1.08 | 0.28 |
| JM Arbitrage DP (B-Quar) | 1.08 | 0.28 |
| JM Arbitrage DP (G) | 1.08 | 0.28 |
| JM Arbitrage DP (I) | 1.08 | 0.28 |
| JM Arbitrage DP (I-Annu) | 1.08 | 0.28 |
| JM Arbitrage DP (I-Half) | 1.08 | 0.28 |
| JM Arbitrage DP (I-Mont) | 1.08 | 0.28 |
| JM Arbitrage DP (I-Quar) | 1.08 | 0.28 |
| WhiteOakELSSTaxSav (G) | 1.31 | 0.28 |
| WhiteOakELSSTaxSav (I) | 1.31 | 0.28 |
| WhiteOakELSSTaxSavDP (G) | 1.31 | 0.28 |
| WhiteOakELSSTaxSavDP (I) | 1.31 | 0.28 |
| Union EquSavings (G) | 0.38 | 0.27 |
| Union EquSavings (I) | 0.38 | 0.27 |
| Union EquSavings DP (G) | 0.38 | 0.27 |
| Union EquSavings DP (I) | 0.38 | 0.27 |
| Zerodha NifLM8-13YDP (G) | 0.05 | 0.25 |
| EdelNifLM8-13YGSec (G) | 0.12 | 0.25 |
| EdelNifLM8-13YGSec (I-Mont) | 0.12 | 0.25 |
| EdelNifLM8-13YGSec (I-Quar) | 0.12 | 0.25 |
| EdelNifLM8-13YGSecDP (G) | 0.12 | 0.25 |
| EdelNifLM8-13YGSecDP (I-Mont) | 0.12 | 0.25 |
| EdelNifLM8-13YGSecDP (I-Quar) | 0.12 | 0.25 |
| JioBR SectorRotatiDP (G) | 0.39 | 0.24 |
| BajajFinsArbitrage (G) | 2.86 | 0.24 |
| BajajFinsArbitrage (I) | 2.86 | 0.24 |
| BajajFinsArbitrageDP (G) | 2.86 | 0.24 |
| BajajFinsArbitrageDP (I) | 2.86 | 0.24 |
| Nippon Nif500EqlWeDP (G) | 1.04 | 0.21 |
| Nippon Nif500EqlWeDP (I) | 1.04 | 0.21 |
| Nippon Nif500EqlWeig (G) | 1.04 | 0.21 |
| Nippon Nif500EqlWeig (I) | 1.04 | 0.21 |
| PGIM EqSavings (G) | 0.12 | 0.21 |
| PGIM EqSavings (I) | 0.12 | 0.21 |
| PGIM EqSavings (I-Annu) | 0.12 | 0.21 |
| PGIM EqSavings (I-Mont) | 0.12 | 0.21 |
| PGIM EqSavings (I-Quar) | 0.12 | 0.21 |
| PGIM EqSavingsDP (G) | 0.12 | 0.21 |
| PGIM EqSavingsDP (I) | 0.12 | 0.21 |
| PGIM EqSavingsDP (I-Annu) | 0.12 | 0.21 |
| PGIM EqSavingsDP (I-Half) | 0.12 | 0.21 |
| PGIM EqSavingsDP (I-Mont) | 0.12 | 0.21 |
| PGIM EqSavingsDP (I-Quar) | 0.12 | 0.21 |
| AdityaBSLMSCIInETF (G) | 0.02 | 0.20 |
| DSP MSCIINDIA ETF (G) | 0.01 | 0.20 |
| Kotak MSCIIndiaETF (G) | 3.22 | 0.20 |
| 360ONEMSCI IndiETF (G) | 0.01 | 0.20 |
| HDFC Nif500MulticaDP (G) | 0.86 | 0.18 |
| HDFC Nif500Multicap (G) | 0.86 | 0.18 |
| Kotak Equity Savings (G) | 18.39 | 0.18 |
| Kotak Equity Savings (I-Mont) | 18.39 | 0.18 |
| Kotak Equity Savings (MIDCWR) | 18.39 | 0.18 |
| Kotak EquitySavingDP (G) | 18.39 | 0.18 |
| Kotak EquitySavingDP (I-Mont) | 18.39 | 0.18 |
| Mirae Nif500MultiCap (G) | 0.15 | 0.18 |
| Groww Nifty200ETF (G) | 0.03 | 0.17 |
| Navi Nif500MulticaDP (G) | 0.05 | 0.17 |
| Navi Nif500Multicap (G) | 0.05 | 0.17 |
| Axis Nifty500Index (G) | 0.46 | 0.15 |
| Axis Nifty500IndexDP (G) | 0.46 | 0.15 |
| DSP Nifty500 Index (G) | 0.02 | 0.15 |
| DSP Nifty500 Index (I) | 0.02 | 0.15 |
| DSP Nifty500 IndexDP (G) | 0.02 | 0.15 |
| DSP Nifty500 IndexDP (I) | 0.02 | 0.15 |
| HDFC BSE500 ETF (G) | 0.07 | 0.15 |
| HDFC BSE500 Index (G) | 0.46 | 0.15 |
| HDFC BSE500 IndexDP (G) | 0.46 | 0.15 |
| SBI Nif500 Index (G) | 1.14 | 0.15 |
| SBI Nif500 Index (I) | 1.14 | 0.15 |
| SBI Nif500 IndexDP (G) | 1.14 | 0.15 |
| SBI Nif500 IndexDP (I) | 1.14 | 0.15 |
| Motilal Os Nif500 (G) | 4.36 | 0.15 |
| Motilal Os Nif500DP (G) | 4.36 | 0.15 |
| Motilal Nifty500ETF (G) | 0.44 | 0.15 |
| ICICI Pru Nifty500 (G) | 0.13 | 0.15 |
| ICICI Pru Nifty500 (I) | 0.13 | 0.15 |
| ICICI Pru Nifty500DP (G) | 0.13 | 0.15 |
| ICICI Pru Nifty500DP (I) | 0.13 | 0.15 |
| ICICIPru BSE500ETF (G) | 0.52 | 0.15 |
| Groww NifTotalMar (G) | 0.51 | 0.14 |
| Groww NifTotalMar (I) | 0.51 | 0.14 |
| Groww NifTotalMarDP (G) | 0.51 | 0.14 |
| Groww NifTotalMarDP (I) | 0.51 | 0.14 |
| Mirae NifTotMarket (G) | 0.07 | 0.14 |
| Mirae NifTotMarket (I) | 0.07 | 0.14 |
| Mirae NifTotMarketDP (G) | 0.07 | 0.14 |
| Mirae NifTotMarketDP (I) | 0.07 | 0.14 |
| AngelOne NifTotETF (G) | 0.06 | 0.14 |
| AngelOneNifTotIndx (G) | 0.08 | 0.14 |
| AngelOneNifTotIndxDP (G) | 0.08 | 0.14 |
| BandhanNifTotalMar (G) | 0.09 | 0.14 |
| BandhanNifTotalMarDP (G) | 0.09 | 0.14 |
| MotilalBSE1000Indx (G) | 0.09 | 0.14 |
| MotilalBSE1000IndxDP (G) | 0.09 | 0.14 |
| WhiteOak FlexiCap (G) | 11.19 | 0.13 |
| WhiteOak FlexiCap (I) | 11.19 | 0.13 |
| WhiteOak FlexiCapDP (G) | 11.19 | 0.13 |
| WhiteOak FlexiCapDP (I) | 11.19 | 0.13 |
| SBI Arbitrage Oppr (G) | 45.57 | 0.10 |
| SBI Arbitrage Oppr (I) | 45.57 | 0.10 |
| SBI Arbitrage Oppr (IDCWR) | 45.57 | 0.10 |
| SBI Arbitrage OpprDP (G) | 45.57 | 0.10 |
| SBI Arbitrage OpprDP (I) | 45.57 | 0.10 |
| SBI Arbitrage OpprDP (IDCWR) | 45.57 | 0.10 |
| WhiteOak MulAsAllo (G) | 5.16 | 0.07 |
| WhiteOak MulAsAlloDP (G) | 5.16 | 0.07 |
| Tata BalanceAdvant (G) | 5.60 | 0.06 |
| Tata BalanceAdvant (I) | 5.60 | 0.06 |
| Tata BalanceAdvant (I-Rein) | 5.60 | 0.06 |
| Tata BalanceAdvantDP (G) | 5.60 | 0.06 |
| Tata BalanceAdvantDP (I) | 5.60 | 0.06 |
| Tata BalanceAdvantDP (I-Rein) | 5.60 | 0.06 |
| AdityaBSL Arbit (G) | 14.32 | 0.05 |
| AdityaBSL Arbit (I) | 14.32 | 0.05 |
| AdityaBSL Arbit (IDCWR) | 14.32 | 0.05 |
| AdityaBSL Arbit DP (G) | 14.32 | 0.05 |
| AdityaBSL Arbit DP (I) | 14.32 | 0.05 |
| AdityaBSL Arbit DP (IDCWR) | 14.32 | 0.05 |
| Bandhan Arbitrage (AIDCWR) | 4.01 | 0.05 |
| Bandhan Arbitrage (G) | 4.01 | 0.05 |
| Bandhan Arbitrage (I-Annu) | 4.01 | 0.05 |
| Bandhan Arbitrage (I-Mont) | 4.01 | 0.05 |
| Bandhan Arbitrage (MIDCWR) | 4.01 | 0.05 |
| Bandhan Arbitrage DP (AIDCWR) | 4.01 | 0.05 |
| Bandhan Arbitrage DP (G) | 4.01 | 0.05 |
| Bandhan Arbitrage DP (I-Annu) | 4.01 | 0.05 |
| Bandhan Arbitrage DP (I-Mont) | 4.01 | 0.05 |
| Kotak Arbitrage Dp (G) | 28.83 | 0.04 |
| Kotak Arbitrage Dp (I) | 28.83 | 0.04 |
| Kotak Arbitrage RP (G) | 28.83 | 0.04 |
| Kotak Arbitrage RP (I) | 28.83 | 0.04 |
| Kotak Arbitrage RP (IDCWR) | 28.83 | 0.04 |
| AdityaBSL Bal Adv (G) | 3.50 | 0.04 |
| AdityaBSL Bal Adv (I) | 3.50 | 0.04 |
| AdityaBSL Bal Adv (IDCWR) | 3.50 | 0.04 |
| AdityaBSL BalAdv DP (G) | 3.50 | 0.04 |
| AdityaBSL BalAdv DP (I) | 3.50 | 0.04 |
| AdityaBSL BalAdv DP (IDCWR) | 3.50 | 0.04 |
| ICICI Pru ArbitDP (G) | 11.07 | 0.03 |
| ICICI Pru ArbitDP (I) | 11.07 | 0.03 |
| ICICI Pru ArbitDP (IDCWR) | 11.07 | 0.03 |
| ICICI Pru Arbitrage (G) | 11.07 | 0.03 |
| ICICI Pru Arbitrage (I) | 11.07 | 0.03 |
| ICICI Pru Arbitrage (IDCWR) | 11.07 | 0.03 |
| Edelweiss ArbitragDP (G) | 3.95 | 0.03 |
| Edelweiss ArbitragDP (I) | 3.95 | 0.03 |
| Edelweiss ArbitragDP (I-Mont) | 3.95 | 0.03 |
| Edelweiss Arbitrage (B) | 3.95 | 0.03 |
| Edelweiss Arbitrage (G) | 3.95 | 0.03 |
| Edelweiss Arbitrage (I) | 3.95 | 0.03 |
| Edelweiss Arbitrage (I-Mont) | 3.95 | 0.03 |
| Edelweiss Arbitrage (I-Rein) | 3.95 | 0.03 |
| Edelweiss EqSav (B) | 0.45 | 0.03 |
| Edelweiss EqSav (G) | 0.45 | 0.03 |
| Edelweiss EqSav (I) | 0.45 | 0.03 |
| Edelweiss EqSav (I-Mont) | 0.45 | 0.03 |
| Edelweiss EqSav DP (B) | 0.45 | 0.03 |
| Edelweiss EqSav DP (G) | 0.45 | 0.03 |
| Edelweiss EqSav DP (I) | 0.45 | 0.03 |
| Edelweiss EqSav DP (I-Mont) | 0.45 | 0.03 |
| Kotak BalanceAdvan (G) | 4.77 | 0.03 |
| Kotak BalanceAdvan (I) | 4.77 | 0.03 |
| Kotak BalanceAdvanDP (G) | 4.77 | 0.03 |
| Kotak BalanceAdvanDP (I) | 4.77 | 0.03 |
| WhiteOak MultiCap (G) | 1.15 | 0.03 |
| WhiteOak MultiCap DP (G) | 1.15 | 0.03 |
| Nippon Arbitrage (G) | 0.95 | 0.01 |
| Nippon Arbitrage (I) | 0.95 | 0.01 |
| Nippon Arbitrage (I-Mont) | 0.95 | 0.01 |
| Nippon Arbitrage (I-Rein) | 0.95 | 0.01 |
| Nippon Arbitrage (M) | 0.95 | 0.01 |
| Nippon ArbitrageDP (G) | 0.95 | 0.01 |
| Nippon ArbitrageDP (I) | 0.95 | 0.01 |
| Nippon ArbitrageDP (I-Mont) | 0.95 | 0.01 |
| Mirae MulAsseAllco (G) | 0.32 | 0.01 |
| Mirae MulAsseAllco (I) | 0.32 | 0.01 |
| Mirae MulAsseAllcoDP (G) | 0.32 | 0.01 |
| Mirae MulAsseAllcoDP (I) | 0.32 | 0.01 |
| HDFC Arbitr WP DP (G) | 0.95 | 0.00 |
| HDFC Arbitr WP DP (I) | 0.95 | 0.00 |
| HDFC Arbitr WP DP (I-Mont) | 0.95 | 0.00 |
| HDFC Arbitrage - WP (G) | 0.95 | 0.00 |
| HDFC Arbitrage - WP (I) | 0.95 | 0.00 |
| HDFC Arbitrage - WP (I-Mont) | 0.95 | 0.00 |
| HDFC Arbitrage - WP (MIDCWR) | 0.95 | 0.00 |
| WhiteoakLar&MidCap (G) | 0.04 | 0.00 |
| WhiteoakLar&MidCapDP (G) | 0.04 | 0.00 |
| WhiteOakPar&Health (G) | 0.01 | 0.00 |
| WhiteOakPar&HealthDP (G) | 0.01 | 0.00 |
Peers
Other companies within the same industry or sector that are comparable to Mankind Pharma Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 687.15 | -0.78 | 0.00 | 1412.22 | -26.19 | 0.73 |
| Lotus Eye Hospital and Institute Ltd | 118.05 | 0.50 | 3935.00 | 5145.94 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 7.61 | -0.39 | 25.37 | 32282.20 | 15.42 | 0.00 |
| Astec Lifesciences Ltd | 633.00 | 0.75 | 0.00 | 5513.59 | -363.14 | 0.00 |
Company Info
The Company was incorporated on July 3, 1991 as a private limited company under the Companies Act, 1956, with the name "Mankind Pharma Private Limited", pursuant to a certificate of incorporation granted by the Registrar of Companies, Delhi and Haryana, at New Delhi ("RoC"). Pursuant to the conversion of the Company to a public limited company and as approved by the Shareholders pursuant to a special resolution dated July 14, 2005 the name of the Company was changed to "Mankind Pharma Limited" and the RoC issued a fresh certificate of incorporation on April 13, 2006.Major events and milestones:2004 -Entered the chronic pharmaceutical segment with the launch of `Amlokind' tablets and `Glimestar' tablets amongst others2005 -Set up the first manufacturing facility at Paonta Sahib, Himachal Pradesh-Entered the ophthalmic pharmaceutical segment with the launch of `Lubistar Eye Drops' and `Tobastar Eye Drops' amongst others2007 -Entered the consumer healthcare segment with the launch of `Manforce' brand-Entered the animal healthcare segment with launch of `Bandykind' and `Ceftiforce' amongst othersRaised Rs.720 million from Monet Limited2009 -Set up the manufacturing facility at Unit II, Paonta Sahib, Himachal Pradesh2010 -Launched `Preganews' brand in the consumer healthcare segment2012 -Setup the first R&D centre at IMT Manesar, Haryana2014 -Acquired Shree Jee Laboratory Private Limited (along with its API manufacturing site situated at Behror, Rajasthan)-Set up the manufacturing facility at Unit III, Paonta Sahib, Himachal Pradesh2015 -Incorporated the Subsidiary, Lifestar Pharma LLC in the US-Incorporated the Subsidiary, Mankind Pharma Pte. Limited in Singapore2017 -Set up the manufacturing facility in Sikkim2018 -The manufacturing facility at Paonta Sahib, Himachal Pradesh was inspected by the USFDA for the first time2019 -Entered the female infertility segment with the launch of `Dydroboon' tablets2020 -Incorporated the Subsidiary, Lifestar Pharmaceuticals Private Limited in Nepal-Launched a dedicated specialty therapeutic division for cardiovascular diseases drugs segment with launch of `Cilaheart' tablets and `Statpure' tablets-Launched a dedicated specialty therapeutic division for diabetes pharmaceuticals segment with launch of `Zukanorm' tablets2021 -Incorporated the Subsidiary, Mankind Pharma FZ-LLC in Dubai, UAE-Launched a specialty division for therapeutic respiratory pharmaceuticals with launch of `Mlife' tablets-Entered the specialty therapeutic neuro/central nervous system pharmaceuticals segment with launch of `Trugaba-NT' tablets and `Prebris-MNT' tablets2022 -Acquired the pharmaceutical formulations brands in India and Nepal from Panacea Biotec Pharma Limited and Panacea Biotec Limited-Entered into transplant segment with the launch of `Pangraf Capsules' and `Mycept' tablets amongst others-Entered into oncology segment with the launch of `Pacliall' injection amongst others-Acquired the brands `Daffy' and `Combihale' from Dr. Reddy's Laboratories-The Subsidiary, Mankind Life Sciences Private Limited acquired 90.00% of the issued, subscribed and paid-up share capital of Upakarma Ayurveda Private Limited. 2023-Mankind Pharma Sets New Industry Standard with Unprecedented Display on Burj Khalifa, Reinforcing Commitment to Excellence.-Mankind Pharma announced its partnership with SpiceJet to raise awareness about DMF-grade API.-Mankind Pharma Product Prega News and Sonam Kapoor partners to transform from pregnancy detection card to pregnancy care solution.2024-Mankind Pharma Completes Landmark Acquisition of BSV.-Mankind Pharma and Innovent Biologics Partner to Revolutionize Cancer Care in India with Innovative Immunotherapy Sintilimab.-Mankind Pharma Launches 45-Day Healthcare Mission at Mahakumbh Serving Thousands of Pilgrims with Free Health Check-ups.-Mankind Pharma Prodct Healthok has joined hands with Bikanervala, (Multinational Indian Restaurant and Sweets Chain). 2025-The Scheme of Arrangement for Amalgamation amongst Shree Jee Laboratory Private Limited , JPR Labs Private Limited and Jaspack Industries Private Limited with Mankind Pharma Limited
The Company was incorporated on July 3, 1991 as a private limited company under the Companies Act, 1956, with the name "Mankind Pharma Private Limited", pursuant to a certificate of incorporation granted by the Registrar of Companies, Delhi and Haryana, at New Delhi ("RoC"). Pursuant to the conversion of the Company to a public limited company and as approved by the Shareholders pursuant to a special resolution dated July 14, 2005 the name of the Company was changed to "Mankind Pharma Limited" and the RoC issued a fresh certificate of incorporation on April 13, 2006.Major events and milestones:2004 -Entered the chronic pharmaceutical segment with the launch of `Amlokind' tablets and `Glimestar' tablets amongst others2005 -Set up the first manufacturing facility at Paonta Sahib, Himachal Pradesh-Entered the ophthalmic pharmaceutical segment with the launch of `Lubistar Eye Drops' and `Tobastar Eye Drops' amongst others2007 -Entered the consumer healthcare segment with the launch of `Manforce' brand-Entered the animal healthcare segment with launch of `Bandykind' and `Ceftiforce' amongst othersRaised Rs.720 million from Monet Limited2009 -Set up the manufacturing facility at Unit II, Paonta Sahib, Himachal Pradesh2010 -Launched `Preganews' brand in the consumer healthcare segment2012 -Setup the first R&D centre at IMT Manesar, Haryana2014 -Acquired Shree Jee Laboratory Private Limited (along with its API manufacturing site situated at Behror, Rajasthan)-Set up the manufacturing facility at Unit III, Paonta Sahib, Himachal Pradesh2015 -Incorporated the Subsidiary, Lifestar Pharma LLC in the US-Incorporated the Subsidiary, Mankind Pharma Pte. Limited in Singapore2017 -Set up the manufacturing facility in Sikkim2018 -The manufacturing facility at Paonta Sahib, Himachal Pradesh was inspected by the USFDA for the first time2019 -Entered the female infertility segment with the launch of `Dydroboon' tablets2020 -Incorporated the Subsidiary, Lifestar Pharmaceuticals Private Limited in Nepal-Launched a dedicated specialty therapeutic division for cardiovascular diseases drugs segment with launch of `Cilaheart' tablets and `Statpure' tablets-Launched a dedicated specialty therapeutic division for diabetes pharmaceuticals segment with launch of `Zukanorm' tablets2021 -Incorporated the Subsidiary, Mankind Pharma FZ-LLC in Dubai, UAE-Launched a specialty division for therapeutic respiratory pharmaceuticals with launch of `Mlife' tablets-Entered the specialty therapeutic neuro/central nervous system pharmaceuticals segment with launch of `Trugaba-NT' tablets and `Prebris-MNT' tablets2022 -Acquired the pharmaceutical formulations brands in India and Nepal from Panacea Biotec Pharma Limited and Panacea Biotec Limited-Entered into transplant segment with the launch of `Pangraf Capsules' and `Mycept' tablets amongst others-Entered into oncology segment with the launch of `Pacliall' injection amongst others-Acquired the brands `Daffy' and `Combihale' from Dr. Reddy's Laboratories-The Subsidiary, Mankind Life Sciences Private Limited acquired 90.00% of the issued, subscribed and paid-up share capital of Upakarma Ayurveda Private Limited. 2023-Mankind Pharma Sets New Industry Standard with Unprecedented Display on Burj Khalifa, Reinforcing Commitment to Excellence.-Mankind Pharma announced its partnership with SpiceJet to raise awareness about DMF-grade API.-Mankind Pharma Product Prega News and Sonam Kapoor partners to transform from pregnancy detection card to pregnancy care solution.2024-Mankind Pharma Completes Landmark Acquisition of BSV.-Mankind Pharma and Innovent Biologics Partner to Revolutionize Cancer Care in India with Innovative Immunotherapy Sintilimab.-Mankind Pharma Launches 45-Day Healthcare Mission at Mahakumbh Serving Thousands of Pilgrims with Free Health Check-ups.-Mankind Pharma Prodct Healthok has joined hands with Bikanervala, (Multinational Indian Restaurant and Sweets Chain). 2025-The Scheme of Arrangement for Amalgamation amongst Shree Jee Laboratory Private Limited , JPR Labs Private Limited and Jaspack Industries Private Limited with Mankind Pharma Limited
Read More
Parent Organisation
Mankind Pharma Ltd.
Founded
03/07/1991
Managing Director
Mr.Rajeev Juneja
NSE Symbol
MANKINDEQ
FAQ
The current price of Mankind Pharma Ltd is ₹2464.50. ₹ 2463.40.
The 52-week high for Mankind Pharma Ltd is ₹2496.55 and the 52-week low is ₹ 2459.35. ₹ 2487.00 and the 52-week low is ₹ 2459.90.
The market capitalization of Mankind Pharma Ltd is currently ₹ 101737.43. ₹ 101737.43. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Mankind Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Mankind Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Mankind Pharma Ltd shares.
The CEO of Mankind Pharma Ltd is Mr.Rajeev Juneja, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.